Ischemic cardiomyopathy is one of the major health problems worldwide,
representing a significant part of mortality in the general population nowadays.
Cardiac magnetic resonance imaging (CMRI) and cardiac computed tomography (CCT)
are noninvasive imaging methods that serve as useful tools in the diagnosis of
coronary artery disease and may also help in screening individuals with risk
factors for developing this illness. Technological developments of CMRI and CCT
have contributed to the rise of several clinical indications of these imaging
methods complementarily to other investigation methods, particularly in cases
where they are inconclusive. In terms of accuracy, CMRI and CCT are similar to
the other imaging methods, with few absolute contraindications and minimal risks
of adverse side-effects. This fact strengthens these methods as powerful and
safe tools in the management of patients. The present study is aimed at
describing the role played by CMRI and CCT in the diagnosis of ischemic
cardiomyopathies.